Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The dual agonist mechanism provides robust glycemic control and significant weight reduction, with clinical trials demonstrating A1C reductions of 1.92.4% and weight loss of approximately 1522% of body weight in non-diabetic adults with obesity (SURMOUNT-1 trial), with more modest weight loss typically observed in patients with type 2 diabetes
Our team will work with you to determine the most appropriate dosing schedule and discuss any available discounts or package deals to best meet your health and financial needs
10.1016/j.amjmed.2014.04.015 30 DangolS.ChenY.HwangB
Open communication with your healthcare provider is essential
US$ 25.95
US$ 24.59
US$ 21.78
US$ 21.57
